Abstract
Parkinson’s disease (PD) is a common progressive, neurodegenerative brain disease that is promoted by mitochondrial dysfunction, oxidative stress, protein aggregation and proteasome dysfunction in the brain. Compared with computer tomography (CT) or magnetic resonance imaging (MRI), non-invasive nuclear radiopharmaceuticals have great significance for the early diagnosis of PD due to their high sensitivity and specificity in atypical and preclinical cases. Based on the development of coordination chemistry and chelator design, radionuclides may be delivered to lesions by attaching to PD-related transporters and receptors, such as dopamine, serotonin, and others. In this review, we comprehensively detailed the current achievements in radionuclide imaging in Parkinson’s disease.
Keywords: Neurodegenerative, Parkinson’s disease, radiopharmaceuticals.
Current Neuropharmacology
Title:Recent Progress of Imaging Agents for Parkinson’s Disease
Volume: 12 Issue: 6
Author(s): Xiaoai Wu, Huawei Cai, Ran Ge, Lin Li and Zhiyun Jia
Affiliation:
Keywords: Neurodegenerative, Parkinson’s disease, radiopharmaceuticals.
Abstract: Parkinson’s disease (PD) is a common progressive, neurodegenerative brain disease that is promoted by mitochondrial dysfunction, oxidative stress, protein aggregation and proteasome dysfunction in the brain. Compared with computer tomography (CT) or magnetic resonance imaging (MRI), non-invasive nuclear radiopharmaceuticals have great significance for the early diagnosis of PD due to their high sensitivity and specificity in atypical and preclinical cases. Based on the development of coordination chemistry and chelator design, radionuclides may be delivered to lesions by attaching to PD-related transporters and receptors, such as dopamine, serotonin, and others. In this review, we comprehensively detailed the current achievements in radionuclide imaging in Parkinson’s disease.
Export Options
About this article
Cite this article as:
Wu Xiaoai, Cai Huawei, Ge Ran, Li Lin and Jia Zhiyun, Recent Progress of Imaging Agents for Parkinson’s Disease, Current Neuropharmacology 2014; 12 (6) . https://dx.doi.org/10.2174/1570159X13666141204221238
DOI https://dx.doi.org/10.2174/1570159X13666141204221238 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Systems Medicine Approaches to Improving Understanding, Treatment, and Clinical Management of Neuroendocrine Prostate Cancer
Current Pharmaceutical Design Metabotropic Glutamate Receptors in the Control of Neuronal Activity and as Targets for Development of Anti-Epileptogenic Drugs
Current Medicinal Chemistry Editorial (Thematic Issue: Vitamin D Supplementation: Its Relevance to Obesity, Atopic Dermatitis and Depression)
Current Nutrition & Food Science Roles of Growth Factors in Chemotherapy-Induced Intestinal Mucosal Damage Repair
Current Pharmaceutical Biotechnology Microenvironment and Brain Tumor Stem Cell Maintenance: Impact of the Niche
Anti-Cancer Agents in Medicinal Chemistry Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors
Current Topics in Medicinal Chemistry Nature and Nurture in the Early-Life Origins of Metabolic Syndrome
Current Pharmaceutical Biotechnology An Update on Hepatic Stem Cells: Bench to Bedside
Current Pharmaceutical Biotechnology Stem Cell and Idiopathic Pulmonary Fibrosis: Mechanisms and Treatment
Current Stem Cell Research & Therapy The Pharmacogenetics of Asthma Therapy
Current Drug Targets Frequency of bla<sub>IMP</sub> and bla<sub>SPM</sub> Metallo-β-Lactamase Genes among Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Clinical Isolates in Sari, North of Iran
Recent Advances in Anti-Infective Drug Discovery Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines
CNS & Neurological Disorders - Drug Targets Past, Recent Progresses and Future Perspectives of Nanotechnology Applied to Antifungal Agents
Current Drug Metabolism Repulsive Apoptosis During Exposure of Mesencephalic Neural Stem Cells to Silver Nanoparticles in a Neurosphere Assay In Vitro
Current Drug Discovery Technologies Antibacterial Peptides and Gastrointestinal Diseases
Current Pharmaceutical Design The Development of Future Research Strategies from Reviewing Antiemetic Trials for Chemotherapy Induced Emesis
Reviews on Recent Clinical Trials Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
Current Molecular Medicine Appropriate Utilization of Restricted Antibiotics in a General Hospital of a Perfecture Area in Greece
Current Drug Safety The Multifunctional Protein C System
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Aluminum Vaccine Adjuvants: Are they Safe?
Current Medicinal Chemistry